About Curia
Curia is a company based in Albany (United States) founded in 1991 was acquired by Aledade in February 2023. It operates as a Professional Services and Managed Services. The company has 11 employees as of April 02, 2024. Curia has completed 9 acquisitions, including ComGenex, Curia and Curia. Curia offers products and services including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product. Curia operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and AmplifyBio, among others.
- Headquarter Albany, United States
- Employees 11 as on 02 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curia Global, Inc.
- Date of Incorporation 25 Jan, 2005
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$31.26 M (USD)-3.24as on Mar 31, 2023
-
Net Profit
$4.84 M (USD)0.3as on Mar 31, 2023
-
EBITDA
$6.04 M (USD)7.37as on Mar 31, 2023
-
Latest Funding Round
$961.21 K (USD), Grant
Apr 22, 2021
-
Investors
Aledade
& 2 more
-
Employee Count
11
as on Apr 02, 2024
-
Investments & Acquisitions
ComGenex
& 8 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Services for small molecule drug discovery and manufacturing.
Comprehensive capabilities for generic API discovery and manufacturing.
Expert services in biologics discovery and sterile manufacturing.
Development and manufacturing services for sterile drug products.
People of Curia
Unlock access to complete
Software Development Team
87 people
Leadership Team
31 people
Senior Team
28 people
Operations Team
16 people
Product Management Team
14 people
Human Resources and Administration
12 people
Sales and Marketing
10 people
Finance and Accounting
9 people
Unlock access to complete
Funding Insights of Curia
Investors in Curia
Curia has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Aledade, SBIR and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Federal innovation and scientific achievement services are provided.
|
Locked | Locked | Locked | |
|
Primary care physician platform for patient care delivery is provided.
|
Locked | Locked | Locked |
Investor details for Curia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curia
Curia has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include ComGenex, Curia and Curia.
Investment portfolio details for Curia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
Locked | Locked | 2009 | Locked | |
|
CMO specializing in injectables and lyophilized biological and pharmaceutical products
|
Locked | Locked | 2008 | Locked | |
|
Contract developer and manufacturer of formulation and GMP filling of biologics
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Curia
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Curia
Detailed financials for Curia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curia Comparisons
Peer comparison for Curia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curia
Curia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and AmplifyBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of Curia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curia
Complete news archive for Curia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curia
Curia was founded in 1991 and raised its 1st funding round 8 years after it was founded.
Curia is headquartered in Albany, United States.
As of Apr 02, 2024, the latest employee count at Curia is 11.
Annual revenue of Curia is $31.26M as on Mar 31, 2023.
Curia is established as a leading global contract development and manufacturing organization (CDMO) with over 30 years of experience in the pharmaceutical and biopharmaceutical sectors. Services are provided across small molecules, generic APIs, and biologics, encompassing drug discovery, development, and manufacturing. Solutions are tailored to meet complex challenges through a network of 23 facilities across North America, Europe, and India. Advanced technologies and dedicated teams are utilized to ensure flexibility and scalability, accelerating the delivery of therapies to patients. Expertise is backed by deep scientific knowledge and a commitment to quality and collaboration.
Curia offers Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.